Medifast, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2020 | 65.4% | 65.4% | 37.3% |
| FY2021 | 81.0% | 81.0% | 41.2% |
| FY2022 | 92.6% | 92.6% | 45.4% |
| FY2023 | 49.3% | 49.3% | 32.1% |
| FY2024 | 1.0% | 1.0% | 0.7% |
| FY2025 | -9.4% | -9.4% | -7.5% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2020 | 65.4% | 65.4% | 37.3% |
| FY2021 | 81.0% | 81.0% | 41.2% |
| FY2022 | 92.6% | 92.6% | 45.4% |
| FY2023 | 49.3% | 49.3% | 32.1% |
| FY2024 | 1.0% | 1.0% | 0.7% |
| FY2025 | -9.4% | -9.4% | -7.5% |